A urine analysis, called a urine proteome, found higher expression of specific proteins in people with different subtypes of Batten disease, a study reports. These proteins may be useful as easily accessible biomarkers of disease progression and response to treatment, its researchers wrote. They might also be potential therapeutic targets. The study, “Urine proteomics analysis of patients with neuronal ceroid lipofuscinoses,” was published in the journal iScience.  Batten disease, also called neuronal ceroid lipofuscinosis (NCL), is…

You must be logged in to read/download the full post.